Logo

American Heart Association

  1
  0


Final ID: TP117

Efficacy And Safety Of Ambulance-Based Prehospital Transdermal Glyceryl Trinitrate In Patients With Acute Presumed Stroke. A Meta-Analysis Of Randomized Controlled Trials.

Abstract Body: Background: Uncontrolled high blood pressure is a risk factor for acute stroke and a predictor of poor stroke outcomes. Less is known about the efficacy and safety of early ambulance-delivered blood pressure reduction on clinical and functional outcomes in patients with undifferentiated acute stroke.

Methods: PubMed, Scopus, and Cochrane databases were searched for randomized controlled trials that compared intervention (with glyceryl trinitrate) to usual blood pressure care or sham in patients with undifferentiated acute stroke; the outcomes of day 90 modified Rankin scale (mRS) maximum score of 6, EuroQol-5D score, National Institutes of Health Stroke Scale (NIHSS ) score at hospital admission, death within 90 days, Barthel index at 90 days, and home time. Heterogeneity was examined using I2 statistics.

Results: We included 3 RCTs with 3547 Patients, of whom 388 received intervention with glyceryl trinitrate. The pooled results of the included 3 RCTs comparing Intervention with glyceryl trinitrate to usual care or sham treatment showed that the death within 90 days (21.9% vs 21.1% respectively; OR = 1.05; 95% CI [0.89, 1.24]; I2 = 0%; p = 0.546), EuroQol-5D-5L score (MD = -0.00; 95% CI [-0.03, 0.03]; I2 = 0%; p = 0.98), NIHSS score at hospital admission (MD = 0.18; 95% CI [-0.70, 1.06]; I2 = 0%; p = 0.69), day 90 mRS maximum score at 6 (MD = 0.01; 95% CI [-0.25, 0.27]; I2 = 0%; p = 0.94), NIHSS score at 24 hours (MD = 0.56; 95% CI [-0.16, 1.27]; I2 = 0%; p = 0.13), Barthel index at 90 days (MD = -2.56; 95% CI [-7.90, 2.78]; I2 = 0%; p = 0.35), and home time (MD = 0.22 days; 95% CI [-5.02, 5.46]; I2 = 0%; p = 0.93) were not statistically different between the intervention and the usual care groups.

Conclusion: These findings suggest that early ambulance-delivered blood pressure reduction does not have superior efficacy and safety profiles for clinical and functional outcomes compared with usual care or sham treatment in patients with undifferentiated acute stroke.
  • Obi, Ogechukwu  ( NYIT College of Osteopathic Medicine , Glen Cove , New York , United States )
  • Cavalcante, Deivyd  ( Federal University of Maranhao , Sao Luis , Brazil )
  • Nweze, Uchenna  ( University of Massachusetts Global , Aliso Viejo , California , United States )
  • Asonye, Patricia  ( UIC College of Pharmacy , Chicago , Illinois , United States )
  • Ariahu, Nonso  ( University of Lagos , Lagos , Lagos , Nigeria )
  • Lee, Timothy  ( Optum , Roslyn Heights , New York , United States )
  • Author Disclosures:
    OGECHUKWU OBI: DO NOT have relevant financial relationships | Deivyd Cavalcante: DO NOT have relevant financial relationships | Uchenna Nweze: DO NOT have relevant financial relationships | Patricia Asonye: DO NOT have relevant financial relationships | Nonso Ariahu: DO NOT have relevant financial relationships | Timothy Lee: No Answer
Meeting Info:
Session Info:

Health Services, Quality Improvement, and Patient-Centered Outcomes Posters II

Thursday, 02/06/2025 , 07:00PM - 07:30PM

Poster Abstract Session

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)